InvestorsHub Logo
Followers 5
Posts 609
Boards Moderated 0
Alias Born 05/16/2008

Re: None

Sunday, 12/13/2009 10:34:04 PM

Sunday, December 13, 2009 10:34:04 PM

Post# of 43
TechniScan Announces Continued OEM Relationship with Esaote , Including Extension to OEM AgreementLast update: 12/10/2009 10:58:00 AM-- Esaote Signs Letter of Intent to Manufacture TechniScan SVARA(TM) System -- SALT LAKE CITY, Dec 10, 2009 (BUSINESS WIRE) -- TechniScan, Inc. (TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, announced today that Genoa, Italy-based Esaote has recently agreed to continue, and extend, its original equipment manufacturing (OEM) agreement with TechniScan. Esaote () -- a medical imaging company specializing in high performance ultrasound systems -- is one of the fastest growing ultrasound companies in the world today. The supplement to the OEM agreement provides for additional support from Esaote for TechniScan's engineering, regulatory and manufacturing initiatives. This support will provide TechniScan with the added resources to complete development of SVARA (TM) and enables TechniScan to focus on development of the TechniScan Imaging Network that allows physicians, patients and payers to safely and efficiently store and transmit image data and records across the network. TechniScan will also focus on sales and marketing while Esaote utilizes its proven manufacturing and regulatory support capabilities to produce the system in its CE-mark qualified manufacturing facility in Genoa, Italy. Esaote will be paid either common stock or cash for its services under the supplement to the OEM agreement, as determined by Esaote anytime during the second quarter of 2010. The parties also signed a non-binding Letter of Intent (LOI) that outlines the terms and approach for Esaote to partner with TechniScan to manufacture and source TechniScan's SVARA (TM) whole breast imaging system. The LOI also addresses Esaote's expectation of marketing and distributing SVARA (TM) under Esaote's own brand, and will pay a license fee to TechniScan calculated as a percentage of Esaote's revenue in Europe. TechniScan Chief Executive Officer David C. Robinson commented, "We are excited that Esaote continues to validate our product and approach by extending our OEM Agreement and we look forward to benefitting from Esaote's proven manufacturing capabilities. This continuation of our agreement further strengthens our partnership and confirms our approach to a global manufacturing and distribution strategy, and continues to validate our technology and partnership choice with Esaote, one of the industry's fastest growing medical imaging companies."